Goodwill in USD of RECURSION PHARMACEUTICALS, INC. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
RECURSION PHARMACEUTICALS, INC. quarterly Goodwill history and change rate from Q2 2020 to Q3 2025.
  • RECURSION PHARMACEUTICALS, INC. Goodwill for the quarter ending 30 Sep 2025 was $162M, a 211% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $162M +$110M +211% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $164M +$112M +216% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $158M +$106M +204% 31 Mar 2025 10-Q 05 May 2025
Q4 2024 $149M +$96.8M +186% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $52.1M -$694K -1.32% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $52.1M -$8.46M -14% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $52.1M +$51.3M +6399% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $52.1M +$51.3M +6399% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $52.8M +$51.9M +6486% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $60.5M +$59.7M +7455% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $801K $0 0% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $801K $0 0% 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $801K $0 0% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $801K $0 0% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $801K $0 0% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $801K $0 0% 31 Dec 2021 10-K 27 Feb 2023
Q3 2021 $801K 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $801K +$801K 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 $801K 31 Mar 2021 10-Q 12 May 2021
Q4 2020 $801K 31 Dec 2020 10-K 23 Mar 2022
Q2 2020 $0 30 Jun 2020 10-Q 13 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.